News & Events

This year’s Arvid Carlsson Award by Sahlgrenska Science Park was awarded to Professor Jens Nielsen.

“Things are progressing quickly now. All major pharmaceutical companies are interested in cell and gene therapy, especially in oncology. It is developing to be as big as antibodies and regular medicines,” says Johan Hyllner, Senior Director, Head of Cell and Gene Therapy, CVRM, at AstraZeneca. You can hear more from Johan on September 26 at the Park Annual event in Gothenburg.

“If you are interested in AI, you shouldn’t forget about VR. There are cool things going on here,” says Almira Thunström, business developer and researcher at Psychiatry Affektiva, Sahlgrenska University Hospital. On September 26, we will meet Almira at the Park Annual event in Gothenburg.

Tens of thousands of people in Europe and the USA are now getting support to build healthier habits and prevent lifestyle diseases. SidekickHealth continues to show that a small, Swedish company can succeed in solving major health challenges, with valuable help from Sahlgrenska Science Park and our Nordic healthtech program. The company is now looking towards significant international growth.

Sweden tops the charts when it comes to sustainable life science solutions. There are considerable opportunities to develop a new large export area. However, deep cross-industry collaboration will be required for this to be achieved.

There are great things happening in Western Sweden’s life science sector. – It is a story that has to be told, says Kenny Genborg, Acting Communications Director, Sahlgrenska Science Park, about a new promotional film produced in collaboration with Business Region Göteborg.

Vitalis has a really good program this year, but when Jennifer Grönqvist, business consultant within healthtech at Sahlgrenska Science Park, tailors her agenda, she has a focus on those who work with long horizons or deep into technology.

Madeleine Rådinger, Associate Professor at the Sahlgrenska Academy, University of Gothenburg, is honored to receive the Cancer and Allergy Fund’s Environmental Medicine Prize 2019, for her research in the asthma area. Sustainable health is important.

Strong collaborations and test beds are important when it comes to the change in life science. Toleranzia received funding from Swelife for their collaboration with Testa Center and presented new and positive results.

When GP report of the first 3D-printed heart, they interview Erik Gatenholm, CEO of CELLINK. – In Sweden there is fantastic capacity and potential, especially at Karolinska, KTH and Sahlgrenska, he says.

It is an increasing trend to use X-rays in surgical procedures. As a consequence, healthcare professionals need safe and functional radiation protection, that are comfortable throughout the surgical procedure.

“We are good at cross sector collaboration in Western Sweden, one of our major competitive advantages”, says Carl-Peter Mattsson, Sahlgrenska Science Park, when attempting to predict the future.